Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH

PHASE3CompletedINTERVENTIONAL
Enrollment

1,550

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

August 29, 2019

Study Completion Date

December 20, 2019

Conditions
Bronchial Asthma
Interventions
DRUG

Test Product

Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg

DRUG

Reference Product

Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg

DRUG

Placebo

Placebo Product

Trial Locations (1)

411004

Maharashtra Medical Foundation Joshi Hospital, Pune

Sponsors
All Listed Sponsors
lead

Aurobindo Pharma Ltd

INDUSTRY

NCT04051710 - Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH | Biotech Hunter | Biotech Hunter